Dr. Thomas Francis Reynolds, MD

Dr. Reynolds practices at Dignity Health - Northridge Hospital Medical Center in Northridge, California, part of CommonSpirit Health.

Dr. Reynolds' NPI, 1457398471, was assigned on May 31, 2006. Dr. Reynolds graduated from Ohio State College of Medicine in 1974. Dr. Reynolds holds California license C43190.

Dr. Reynolds' primary practice is Dignity Health - Northridge Hospital Medical Center, at 18300 Roscoe Blvd, Northridge, CA 91325 in Los Angeles County. The practice phone is (818) 885-8500.

Dr. Reynolds' primary practice is Dignity Health - Northridge Hospital Medical Center in Northridge, California, part of CommonSpirit Health. The medical group on file is Pacific Central Coast Health Centers Medical Group. Dmand AI also links Dr. Reynolds to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Reynolds practices, 3 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Reynolds' primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Reynolds is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Reynolds' licenses on file in 5 states: California, Ohio, Utah, New York and New Jersey.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, deep vein thrombosis (DVT), multiple myeloma, prostate cancer and purpura and thrombocytopenia among the conditions Dr. Reynolds treats.

CMS data shows 182 Medicare services from Dr. Reynolds across 6 procedure codes in 2024, for 113 Medicare patients. Medicare paid $17,751 for them. Every service was in an office.

CMS counts 113 Medicare patients who saw Dr. Reynolds in 2024. The largest group is 65 to 74, with 43 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 62% are also on Medicaid. Their average risk score is 2.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Reynolds' median patient age at 64, with 64% women.

In 2024, Dr. Reynolds wrote 124 Medicare Part D claims for 37 patients. 60% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $166 in total drug cost. In 2022, CMS named 384 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Reynolds for performance year 2024, reported as part of a group. Dr. Reynolds accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Reynolds, published from 2008 to 2009. The most frequent topics are Epilepsy, Costs and Cost Analysis and Socioeconomic Factors. Dr. Reynolds has published most often in Epilepsia. Dr. Reynolds' most frequent co-authors are Michael E. Newmark, MD, Steven C. Karceski, MD and Tina T. Shih, MD.

CMS Open Payments shows 1,035 general payments to Dr. Reynolds from 79 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 91% of the total. Novartis Pharmaceuticals Corporation paid the most, $3,054.

Dr. Reynolds graduated from Ohio State College of Medicine in 1974.

Dr. Reynolds is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.